KAUSHIK PATEL: Open Payments
NPI 1649256843 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 84 payments from 23 companies in 2025. Trend: 2023 $2,006 · 2024 $1,889 · 2025 $1,739
Food & beverage: $1,739
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $261 |
| Novo Nordisk Inc | 12 | $259 |
| Lilly USA, LLC | 12 | $226 |
| Exact Sciences Corporation | 8 | $208 |
| Kowa Pharmaceuticals America, Inc. | 6 | $119 |
| Teva Pharmaceuticals USA, Inc. | 5 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $107 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| ABBVIE INC. | 2 | $41 |
Products named: MOUNJARO, ELIQUIS, Cologuard Collection Kit, ZORYVE, AUSTEDO XR, CAPLYTA, Rybelsus, VERQUVO.
Industry payments across PA — which companies pay providers there.
